Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02533440 · ClinicalTrials.gov registry record · NA

Efficacy of EXPAREL in Comparison to Standard of Care for the Treatment of Post Operative Dental Implant Pain

A NA study of Postoperative Pain, sponsored by Bellaire Facial Surgery Center.

Completed
Registry status
NA
Development phase
69
Enrollment target
3
Study locations

NCT02533440: Completed NA study of Postoperative Pain, sponsored by Bellaire Facial Surgery Center.

NCT02533440 is a NA study of Postoperative Pain that has completed, run by Bellaire Facial Surgery Center. The registered enrollment target is 69 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (70% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02533440, a NA study of Postoperative Pain, has completed, sponsored by Bellaire Facial Surgery Center.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target
3
Study locations

Study Summary

This study is researching managing postsurgical pain by injecting both short-acting local anesthetics and EXPAREL® at the time of surgery and reviewing if it could reduce or eliminate the need for postsurgical opioids and improve clinical outcomes following the FAST dental implant surgery procedure. This approach is being compared to the current standard of care.

Conditions Studied

Interventions

  • PROCEDURE EXPAREL and Local Anesthetics
  • PROCEDURE Oral Opioid and Local Anesthetics

Study Locations (3)

Texas

  • ClearChoice Dental Implants - Houston
  • ClearChoice Dental Implants - The Woodlands

Georgia

  • ClearChoice Dental Implants - Atlanta

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2015-08
Est. Completion 2016-04
Phase NA
Bellaire Facial Surgery Center

1 total trials

What the finished NCT02533440 record still lists

NCT02533440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which EXPAREL and Local Anesthetics is the first listed.

NCT02533440 reports a single indexed study location in Texas, Georgia.

Frequently Asked Questions

What is clinical trial NCT02533440 about?

NCT02533440 is a clinical study titled "Efficacy of EXPAREL in Comparison to Standard of Care for the Treatment of Post Operative Dental Implant Pain". This study is researching managing postsurgical pain by injecting both short-acting local anesthetics and EXPAREL® at the time of surgery and reviewing if it could reduce or eliminate the need for postsurgical opioids and improve clinical outcomes following the FAST dental implant surgery procedure....

What is the current status of trial NCT02533440?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2015-08. Estimated completion is 2016-04.

What conditions does trial NCT02533440 study?

This clinical trial studies the following conditions: Postoperative Pain.

What interventions are being tested in trial NCT02533440?

The interventions under investigation include: EXPAREL and Local Anesthetics (PROCEDURE), Oral Opioid and Local Anesthetics (PROCEDURE).

Who is sponsoring clinical trial NCT02533440?

This trial is sponsored by Bellaire Facial Surgery Center, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02533440 being conducted?

This trial has 3 study locations across Georgia, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02533440's enrollment target sits among peer trials

69 89th of 120 higher than 31 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02533440, the US trial registry maintained by the National Library of Medicine. NCT02533440 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.